Kodiak Sciences (KOD) Accumulated Depreciation (2017 - 2025)
Kodiak Sciences' (KOD) quarterly Accumulated Depreciation came in at $59.5 million in Q4 2025, up 44.13% YoY from $41.3 million in Q4 2024, and up 44.13% on a QoQ basis from $41.3 million in Q4 2024.
Kodiak Sciences (KOD) Accumulated Depreciation (2017 - 2025) Analysis & Trends
Kodiak Sciences (KOD) has 9 years of Accumulated Depreciation data on file, last reported at $59.5 million in Q4 2025.
- Quarterly Accumulated Depreciation rose 44.13% year-over-year to $59.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $59.5 million (up 44.13% YoY) and the FY2025 annual result came in at $59.5 million, up 44.13% from the prior year.
- Accumulated Depreciation climbed to $59.5 million in Q4 2025, from $41.3 million in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $59.5 million in Q4 2025 to a low of $2.9 million in Q4 2021.
- A 5-year average of $26.6 million and a median of $22.6 million in 2023 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2021 — Accumulated Depreciation surged 35.44% — and 2023, when it surged 235.4%.
- Tracing KOD's Accumulated Depreciation over 5 years: stood at $2.9 million in 2021, then surged by 128.79% to $6.7 million in 2022, then surged by 235.4% to $22.6 million in 2023, then jumped by 82.96% to $41.3 million in 2024, then jumped by 44.13% to $59.5 million in 2025.
- The last three Accumulated Depreciation figures came in at $59.5 million (Q4 2025), $41.3 million (Q4 2024), and $22.6 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Kodiak Sciences | 2.60 Bn | 2.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 59.47 Mn |
| Dec 31, 2024 | 41.26 Mn |
| Dec 31, 2023 | 22.55 Mn |
| Dec 31, 2022 | 6.72 Mn |
| Dec 31, 2021 | 2.94 Mn |
| Dec 31, 2020 | 2.17 Mn |
| Dec 31, 2019 | 1.77 Mn |
| Dec 31, 2018 | 1.69 Mn |
| Sep 30, 2018 | 1.82 Mn |
| Dec 31, 2017 | 1.45 Mn |